Free Trial

Emergent BioSolutions (EBS) SEC Filings & 10K Form

Emergent BioSolutions logo
$7.72 -1.55 (-16.72%)
(As of 11/15/2024 ET)

Recent Emergent BioSolutions SEC Filings

DateFilerForm TypeView
11/13/2024
3:00 PM
Emergent BioSolutions (Subject)
OAK HILL ADVISORS LP (Filed by)
Form SC 13G
11/12/2024
9:34 AM
Emergent BioSolutions (Subject)
White Marvin L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
3:12 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
4:04 PM
Emergent BioSolutions (Issuer)
LINDAHL RICHARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
6:29 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
7:11 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
11:09 AM
BlackRock Inc. (Filed by)
Emergent BioSolutions (Subject)
Form SC 13G/A
09/03/2024
6:47 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
7:26 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
3:20 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:34 PM
Emergent BioSolutions (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/31/2024
7:56 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
3:30 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
3:33 PM
Emergent BioSolutions (Issuer)
Fox Jennifer Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
3:33 PM
Emergent BioSolutions (Issuer)
Hartzel William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
3:30 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:02 PM
Emergent BioSolutions (Issuer)
Williams Paul Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
3:32 PM
Emergent BioSolutions (Subject)
Form SC 13G/A
07/02/2024
7:19 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
6:05 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
12:30 PM
BlackRock Inc. (Filed by)
Emergent BioSolutions (Subject)
Form SC 13G/A
05/31/2024
2:02 PM
Emergent BioSolutions (Issuer)
Zoon Kathryn C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:34 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
8:40 PM
Dayal Sujata Tyagi (Reporting)
Emergent BioSolutions (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
8:40 PM
Emergent BioSolutions (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
8:41 PM
DeGolyer Donald W (Reporting)
Emergent BioSolutions (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
8:41 PM
Emergent BioSolutions (Issuer)
Fowler Neal Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
8:41 PM
Emergent BioSolutions (Issuer)
Katkin Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
8:14 PM
Emergent BioSolutions (Issuer)
Richard Ronald (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
8:14 PM
Emergent BioSolutions (Issuer)
Zoon Kathryn C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
8:14 PM
Emergent BioSolutions (Issuer)
Harsanyi Zsolt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
8:14 PM
Emergent BioSolutions (Issuer)
SULLIVAN LOUIS W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
4:15 PM
Emergent BioSolutions (Issuer)
Zoon Kathryn C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
3:44 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
3:05 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
4:22 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
4:26 PM
Emergent BioSolutions (Filer)
Form DEF 14A
04/11/2024
4:27 PM
Emergent BioSolutions (Filer)
Form DEFA14A
04/11/2024
4:28 PM
Emergent BioSolutions (Filer)
Form ARS
04/09/2024
6:27 PM
Emergent BioSolutions (Issuer)
Hartzel William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
6:27 PM
Emergent BioSolutions (Issuer)
Glessner Coleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The Tesla Trade Is Back In Business (Ad)

If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.

Discover how to trade Tesla, simply follow this link here.
03/15/2024
4:15 PM
Emergent BioSolutions (Issuer)
Hartzel William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:15 PM
Emergent BioSolutions (Issuer)
LINDAHL RICHARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:16 PM
Emergent BioSolutions (Issuer)
Fox Jennifer Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:16 PM
Emergent BioSolutions (Issuer)
Glessner Coleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:16 PM
Emergent BioSolutions (Issuer)
Williams Paul Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:16 PM
Emergent BioSolutions (Issuer)
PAPA JOSEPH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:21 PM
Emergent BioSolutions (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2024
7:31 PM
Emergent BioSolutions (Issuer)
Hartzel William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:15 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
5:42 PM
Emergent BioSolutions (Issuer)
Fox Jennifer Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:42 PM
Emergent BioSolutions (Issuer)
LINDAHL RICHARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:43 PM
Emergent BioSolutions (Issuer)
Williams Paul Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:43 PM
Emergent BioSolutions (Issuer)
Glessner Coleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
9:02 AM
Emergent BioSolutions (Issuer)
PAPA JOSEPH C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/27/2024
7:26 PM
Emergent BioSolutions (Issuer)
LINDAHL RICHARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
7:28 PM
Emergent BioSolutions (Issuer)
Fox Jennifer Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
7:30 PM
Emergent BioSolutions (Issuer)
Emergent BioSolutions (Issuer)
Williams Paul Anthony (Reporting)
Williams Paul Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
6:25 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
5:19 PM
CHARLES SCHWAB INVESTMENT MANAGEMENT INC (Filed by)
Emergent BioSolutions (Subject)
Form SC 13G
01/23/2024
9:52 AM
Emergent BioSolutions (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/19/2024
1:40 PM
BlackRock Inc. (Filed by)
Emergent BioSolutions (Subject)
Form SC 13G/A
01/18/2024
3:16 PM
Emergent BioSolutions (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G/A
01/11/2024
6:41 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
7:40 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
6:24 AM
Emergent BioSolutions (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/11/2023
6:17 AM
Emergent BioSolutions (Filer)
Form 10-K/A
11/28/2023
6:15 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2023
6:17 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:EBS) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners